SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001385508-22-000054
Filing Date
2022-05-10
Accepted
2022-05-10 16:09:30
Documents
74
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q opnt-20220331.htm   iXBRL 10-Q 892454
2 EX-31.1 exhibit31103312022.htm EX-31.1 11532
3 EX-31.2 exhibit31203312022.htm EX-31.2 11374
4 EX-32.1 exhibit32103312022.htm EX-32.1 5618
5 EX-32.2 exhibit32203312022.htm EX-32.2 5542
  Complete submission text file 0001385508-22-000054.txt   4999262

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20220331.xsd EX-101.SCH 42555
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20220331_cal.xml EX-101.CAL 48308
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20220331_def.xml EX-101.DEF 249391
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20220331_lab.xml EX-101.LAB 468649
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20220331_pre.xml EX-101.PRE 401968
68 EXTRACTED XBRL INSTANCE DOCUMENT opnt-20220331_htm.xml XML 634869
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38193 | Film No.: 22909655
SIC: 2834 Pharmaceutical Preparations